IDRA - Idera Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Idera Pharmaceuticals's activity chart (see below) currently has 9 price targets and 11 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 58.33% with an average time for these price targets to be met of 507 days.

Most recent stock forecast was given by from WEDBUSH on 19-Mar-2021. First documented stock forecast 27-May-2014.

Best performing analysts who are covering IDRA - Idera Pharmaceuticals:

Robert Driscoll Gena Wang Edward Tenthoff Swayampakula Ramakanth Anupam Rama

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Dec-2018

$5

5 years 6 months 18 days ago
(19-Mar-2021)

2/2 (100%)

$-13.17 (-72.48%)

1016

Buy Since 24-Sep-2018

$34

$26.77 (370.26%)

$238

5 years 6 months 19 days ago
(19-Mar-2021)

0/2 (0%)

$0.37 (1.10%)

Buy Since 09-Sep-2015

$255

5 years 6 months 19 days ago
(19-Mar-2021)

1/2 (50%)

$99.6 (64.09%)

26

Hold Since 19-Mar-2021

$14

5 years 6 months 19 days ago
(19-Mar-2021)

1/1 (100%)

$-32.53 (-69.91%)

984

Buy Since 27-May-2014

$952

$944.77 (13067.36%)

$952

11 years 9 months 21 days ago
(17-Dec-2014)

0/3 (0%)

$423.49 (80.13%)

Show more analysts

Please expand the browser size to see the chart

What is IDRA (Idera Pharmaceuticals) average time for price targets to be met?

On average it took 507 days for the stock forecasts to be reached, with an average price target met ratio of 58.33%.

Which analyst most recently updated their price target on IDRA (Idera Pharmaceuticals)?

Which analyst has the current lower performing score on IDRA (Idera Pharmaceuticals) with a proven track record?

ANUPAM RAMA

Which analyst has the most public recommendations on IDRA (Idera Pharmaceuticals)?

has 0 price targets and 0 ratings on IDRA

Which analyst is the currently most bullish on IDRA (Idera Pharmaceuticals)?

Edward Tenthoff with the highest potential upside of $944.77

Which analyst is the currently most reserved on IDRA (Idera Pharmaceuticals)?

Robert Driscoll with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?